Browsing by Author Colleoni, Marco

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 34  next >
Issue DateTitleAuthor(s)Citation
2016Absolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT TrialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Pinotti, Graziella; Price, Karen N; Regan, Meredith; Tondini, Carlo; Viale, Giuseppe; Walley, Barbara; School of Public Health: Public HealthAbsolute benefit of adjuvant endocrine therapies for premenopausal women with hormone receptor-positive, Human epidermal growth factor receptor 2-Negative early breast cancer: TEXT and SOFT Trials, Journal of Clinical Oncology, vol.34, 19, 2016,pp 2221-2230
2003Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trialCoates, Alan; Bonetti, Marco; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Nasi, M. Laura; O'Neill, Anne; Price, Karen N.; School of Public Health: Public HealthAdjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breat cancer : a randomized trial, Journal of the National Cancer Institute, vol.95,(24),2003,pp 1833-1846
2014Adjuvant exemestane with ovarian suppression in premenopausal breast cancerCoates, Alan; Burstein, Harold J.; Colleoni, Marco; et al, Various; Fleming, G. F.; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Perez, E. A.; Regan, Meredith M.; Tondini, Carlo; Walley, B; School of Public Health: Public HealthAdjuvant exemestane with ovarian suppression in premenopausal breast cancer, New England Journal of Medicine, vol.371, 2, 2014,pp 107-118
2015Adjuvant ovarian suppression in premenopausal breast cancerCoates, Alan; Bellet, Meritxell; Bonnefoi, Herve; Buchholz, Stefan; Burstein, Harold; Ciruelos, Eva; Climent, Miguel; Coleman, Richard; Colleoni, Marco; Da Prada, Gian; Davidson, Nancy; Fleming, Gini; Francis, Prudence; Gelber, Richard D. (Prof); Geyer, Charles; Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Ingle, J.; Kerbrat, Pierre; Lang, Istvan; Maibach, Rudolph; Martino, Silvana; Price, K. N; Rabaglio-Poretti, Manuela; Regan, Meredith; Ruepp, Barbara; Viale, Giuseppe; Walley, Barbara; Winer, EP; School of Public Health: Public HealthAdjuvant ovarian suppression in premenopausal breast cancer, The New England Journal of Medicine, vol.372, 5, 2015,pp 436-446
2013Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trialsCoates, Alan; Colleoni, Marco; Fleming, Gini; Francis, Prudence; Gelber, Richard; Goldhirsch, Aron (Prof); Maibach, Rudolph; Pagani, Olivia; Price, Karen; Rabaglio, Manuela; Regan, Meredith; Ruepp, Barbara; Walley, B; School of Public Health: Public HealthAdjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials, The Breast, vol.22, 6, 2013,pp 1094-1100
2010Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et al, various; Giobbie-Hurder, Anita; Gusterson,, B; Maiorano, Eugenio; Mallon, Elizabeth; Mastropasqua, Mauro G.; Sonzogni, A; Viale, Giuseppe; School of Public Health: Public HealthAdverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer., Annals of Oncology, vol.21, 2,pp 245-254
2011Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 studyCoates, Alan; Chirgwin, Jacquie H; Colleoni, Marco; Forbes, John F.; Gelber, Richard D. (Prof); Giobbie-Hurder, Anita; Goldhirsch, Aron (Prof); Lang, Istvan; Mauriac, L; Mouridsen, Henning; Paridaens, R.J.; Pienkowski, Tadeusz; Price, Karen N.; Regan, Meredith M.; Smith, Ian (Prof); Thurlimann, Beat; Wardley, Andrew; School of Public Health: Public HealthAnalyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study, Journal of Clinical Oncology, vol.29, 9, 2011,pp 1117-1124
2008Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study GroupCoates, Alan; Aebi, Stefan; Byrne, Michael J.; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; et, al; Gianni, Lorenzo; Holmberg, Stig B.; Panzini, Ilaria; Snyder, Raymond; School of Public Health: Public HealthAnemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group, Supportive Care in Cancer, vol.16,(1),2008,pp 67-74
2016Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to VCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Forbes, John F.; Gelber, Richard; Gianni, Lorenzo; Goldhirsch, Aron; Karlsson, Per; Price, Karen; Sun, Zhuoxin; Thurlimann, B.; School of Public Health: Public HealthAnnual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V, Journal of Clinical Oncology, vol.34, 9, 2016,pp 927-935
2007CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trialsCoates, Alan; Colleoni, Marco; Collins, John; Crivellari, D; Dellapasqua, S; et, al; Keshaviah, A; Lindtner, J; Mendiola, C; Rotmensz, N; Thuerlimann, B; School of Public Health: Public HealthCA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials, Annals of Oncology 2005, vol.18,(4),2007,pp 701-708
2017Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 studyCoates, Alan; Ahern, T; Borgquist, Signe; Colleoni, Marco; Debled, Marc; Ejlertsen, Bent; et al, Various; Garber, Judy; Giobbie-Hurder, Anita; Lang, Istvan; von Moos, Roger; NH&MRC Clinical Trials CentreCholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study, Journal of Clinical Oncology, vol.35, 11, 2017,pp 1179-1188
2010Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast CancerCoates, Alan; Cole, Bernard; Colleoni, Marco; Crivellari, Diana; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Gusterson, Barry; Maiorano, Eugenio; Mastropasqua, Mauro G.; Price, Karen N.; Regan, Meredith M.; Viale, Giuseppe; School of Public Health: Public HealthClassical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.28, 18, 2010,pp 2966-2973
2017Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFTCoates, Alan; Abdi, Ehtesham; Colleoni, Marco; Fleming, G. F.; Francis, P A; Gelber, Richard; Goldhirsch, A; Gomez, Henry; Lang, Istvan; Pagani, Olivia; Parmar, Vani; Pinotti, Graziella; Regan, Meredith M.; Ruhstaller, Thomas; Salim, Muhammad; Spazzapan, Simon; Tondini, Carlo; Walley, B. A.; NH&MRC Clinical Trials CentreConcurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: An exploratory analysis of TEXT and SOFT, Annals of Oncology, vol.28, 9, 2017,pp 2225-2232
2002Duration of Adjuvant Chemotherapy for Breast Cancer: A Joint Analysis of Two Randomised Trials Investigating Three Versus Six Courses of CMFCoates, Alan; Bastert, G; Bonetti, M; Castiglione-Gertsch, Monica; Colleoni, Marco; et, al; Gelber, Richard D. (Prof); Litman, H; Rudenstam, Carl-Magnus; Sauerbrei, W; Schumacher, M; School of Public Health: Public HealthDuration of Adjuvant Chemotherapy for Breast Cancer: A Joint Analysis of Two Randomised Trials Investigating Three Versus Six Courses of CMF, British Journal of Cancer, vol.86,(N/A),2002,pp 1705-1714
2009The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.Coates, Alan; Aebi, S; Basser, R; Cinieri, S.; Colleoni, Marco; et al, various; Gelber, RD; Green, M; Martinelli, G; Peccatori, F.; Sun, Zhuoxin; School of Public Health: Public HealthThe effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up., Annals of Oncology, vol.20, 8,pp 1344-1351
2007Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Gelber, Shari; Goldhirsch, Aron (Prof); International, B e; Pagani, O.; Price, Karen N.; Simoncini, Edda; School of Public Health: Public HealthEffects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93, Annals of Oncology 2005, vol.18,(7),2007,pp 1177-1184
2002Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trialCoates, Alan; Bernhard, J; Bonetti,, M; Castiglione-Gertsch, Monica; Colleoni, Marco; Gelber, Richard D. (Prof); Hirsch, D; Nasi,, M; Price, Aaron; Zahrieh, D; School of Public Health: Public HealthEndocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial, Journal of the National Cancer Institute, vol.94,(14),2002,pp 1054-1065
2007Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; et, al; Forbes, John F.; Gelber, Richard D. (Prof); Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Thurlimann, Beat; School of Public Health: Public HealthFive years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(5),2007,pp 486-492
2012Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?Coates, Alan; Colleoni, Marco; Goldhirsch, A; School of Public Health: Public HealthIs Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?, Journal of Clinical Oncology, vol.30, 12, 2012,pp 1260-1263
2009Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.Coates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Collins, John; Crivellari, Diana; Forbes, John F.; Gelber, Richard D. (Prof); Goldhirsch, Aron (Prof); Holmberg, Stig B.; Price, Karen; Thurlimann, Beat; School of Public Health: Public HealthIs chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93., Breast Cancer Research and Treatment, vol.113,(N/A),2009,pp 137-144